Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 457 to 465 of 465 entries
Sorted by: Best Match Show Resources per page
Spray-Congealing and Wet-Sieving as Alternative Processes for Engineering of Inhalation Carrier Particles: Comparison of Surface Properties, Blending and In Vitro Performance.

Pharmaceutical research

Pinto JT, Zellnitz S, Guidi T, Schiaretti F, Schroettner H, Paudel A.
PMID: 34114162
Pharm Res. 2021 Jun;38(6):1107-1123. doi: 10.1007/s11095-021-03061-5. Epub 2021 Jun 10.

PURPOSE: Traditionally, α-lactose monohydrate is the carrier of choice in dry powder inhaler (DPI) formulations. Nonetheless, other sugars, such as D-mannitol, have emerged as potential alternatives. Herein, we explored different particle engineering processes to produce D-mannitol carriers for inhaled...

Cite
Pinto JT, Zellnitz S, Guidi T, et al. Spray-Congealing and Wet-Sieving as Alternative Processes for Engineering of Inhalation Carrier Particles: Comparison of Surface Properties, Blending and In Vitro Performance. Pharm Res. 2021;38(6):1107-1123doi: 10.1007/s11095-021-03061-5.
Pinto, J. T., Zellnitz, S., Guidi, T., Schiaretti, F., Schroettner, H., & Paudel, A. (2021). Spray-Congealing and Wet-Sieving as Alternative Processes for Engineering of Inhalation Carrier Particles: Comparison of Surface Properties, Blending and In Vitro Performance. Pharmaceutical research, 38(6), 1107-1123. https://doi.org/10.1007/s11095-021-03061-5
Pinto, Joana T, et al. "Spray-Congealing and Wet-Sieving as Alternative Processes for Engineering of Inhalation Carrier Particles: Comparison of Surface Properties, Blending and In Vitro Performance." Pharmaceutical research vol. 38,6 (2021): 1107-1123. doi: https://doi.org/10.1007/s11095-021-03061-5
Pinto JT, Zellnitz S, Guidi T, Schiaretti F, Schroettner H, Paudel A. Spray-Congealing and Wet-Sieving as Alternative Processes for Engineering of Inhalation Carrier Particles: Comparison of Surface Properties, Blending and In Vitro Performance. Pharm Res. 2021 Jun;38(6):1107-1123. doi: 10.1007/s11095-021-03061-5. Epub 2021 Jun 10. PMID: 34114162; PMCID: PMC8217042.
Copy Download .nbib Format: NLM
Treatment of necrotizing enterocolitis by conditioned medium derived from human amniotic fluid stem cells.

PloS one

O'Connell JS, Li B, Zito A, Ahmed A, Cadete M, Ganji N, Lau E, Alganabi M, Farhat N, Lee C, Eaton S, Mitchell R, Ray S, De Coppi P, Patel K, Pierro A.
PMID: 34855833
PLoS One. 2021 Dec 02;16(12):e0260522. doi: 10.1371/journal.pone.0260522. eCollection 2021.

PURPOSE: Necrotizing enterocolitis (NEC) is one of the most distressing gastrointestinal emergencies affecting neonates. Amniotic fluid stem cells (AFSC) improve intestinal injury and survival in experimental NEC but are difficult to administer. In this study, we evaluated whether conditioned...

Cite
O'Connell JS, Li B, Zito A, et al. Treatment of necrotizing enterocolitis by conditioned medium derived from human amniotic fluid stem cells. PLoS One. 2021;16(12):e0260522doi: 10.1371/journal.pone.0260522.
O'Connell, J. S., Li, B., Zito, A., Ahmed, A., Cadete, M., Ganji, N., Lau, E., Alganabi, M., Farhat, N., Lee, C., Eaton, S., Mitchell, R., Ray, S., De Coppi, P., Patel, K., & Pierro, A. (2021). Treatment of necrotizing enterocolitis by conditioned medium derived from human amniotic fluid stem cells. PloS one, 16(12), e0260522. https://doi.org/10.1371/journal.pone.0260522
O'Connell, Joshua S, et al. "Treatment of necrotizing enterocolitis by conditioned medium derived from human amniotic fluid stem cells." PloS one vol. 16,12 (2021): e0260522. doi: https://doi.org/10.1371/journal.pone.0260522
O'Connell JS, Li B, Zito A, Ahmed A, Cadete M, Ganji N, Lau E, Alganabi M, Farhat N, Lee C, Eaton S, Mitchell R, Ray S, De Coppi P, Patel K, Pierro A. Treatment of necrotizing enterocolitis by conditioned medium derived from human amniotic fluid stem cells. PLoS One. 2021 Dec 02;16(12):e0260522. doi: 10.1371/journal.pone.0260522. eCollection 2021. PMID: 34855833; PMCID: PMC8638898.
Copy Download .nbib Format: NLM
Dual effects of atorvastatin on angiogenesis pathways in the differentiation of mesenchymal stem cells.

European journal of pharmacology

Khalighfard S, Khori V, Alizadeh AM, Vahabzadeh G, Tajaldini M, Sedighi S, Nozarian Z, Khodayari H, Khodayari S, Ganji F, Veisi Malekshahi Z, Mirmajidi T.
PMID: 34217710
Eur J Pharmacol. 2021 Sep 15;907:174281. doi: 10.1016/j.ejphar.2021.174281. Epub 2021 Jul 01.

Atorvastatin (ATO) can improve the transplantation efficacy of mesenchymal stem cells (MSCs) after acute myocardial infarction. The present study aimed at ATO effects on the angiogenesis-signaling pathways from MSCs' differentiation to tissue angiogenesis. MSCs were first prepared from BALB/c...

Cite
Khalighfard S, Khori V, Alizadeh AM, et al. Dual effects of atorvastatin on angiogenesis pathways in the differentiation of mesenchymal stem cells. Eur J Pharmacol. 2021;907:174281doi: 10.1016/j.ejphar.2021.174281.
Khalighfard, S., Khori, V., Alizadeh, A. M., Vahabzadeh, G., Tajaldini, M., Sedighi, S., Nozarian, Z., Khodayari, H., Khodayari, S., Ganji, F., Veisi Malekshahi, Z., & Mirmajidi, T. (2021). Dual effects of atorvastatin on angiogenesis pathways in the differentiation of mesenchymal stem cells. European journal of pharmacology, 907174281. https://doi.org/10.1016/j.ejphar.2021.174281
Khalighfard, Solmaz, et al. "Dual effects of atorvastatin on angiogenesis pathways in the differentiation of mesenchymal stem cells." European journal of pharmacology vol. 907 (2021): 174281. doi: https://doi.org/10.1016/j.ejphar.2021.174281
Khalighfard S, Khori V, Alizadeh AM, Vahabzadeh G, Tajaldini M, Sedighi S, Nozarian Z, Khodayari H, Khodayari S, Ganji F, Veisi Malekshahi Z, Mirmajidi T. Dual effects of atorvastatin on angiogenesis pathways in the differentiation of mesenchymal stem cells. Eur J Pharmacol. 2021 Sep 15;907:174281. doi: 10.1016/j.ejphar.2021.174281. Epub 2021 Jul 01. PMID: 34217710.
Copy Download .nbib Format: NLM
Mitochondrial complex-I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer's disease.

European journal of neurology

Terada T, Therriault J, Kang MS, Savard M, Pascoal TA, Lussier F, Tissot C, Wang YT, Benedet A, Poltronetti NM, Ottoy J, Arias JF, Bezgin G, Matsudaira T, Bunai T, Obi T, Tsukada H, Ouchi Y, Rosa-Neto P.
PMID: 35007366
Eur J Neurol. 2022 Jan 10; doi: 10.1111/ene.15246. Epub 2022 Jan 10.

BACKGROUND: Abnormal mitochondrial metabolism has been described in Alzheimer's disease (AD) brain. However, the relationship between AD pathophysiology and key mitochondrial processes remains elusive. The purpose of this study is to investigate whether mitochondrial complex I dysfunction is associated...

Cite
Terada T, Therriault J, Kang MS, et al. Mitochondrial complex-I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer's disease. Eur J Neurol. 2022;doi: 10.1111/ene.15246.
Terada, T., Therriault, J., Kang, M. S., Savard, M., Pascoal, T. A., Lussier, F., Tissot, C., Wang, Y. T., Benedet, A., Poltronetti, N. M., Ottoy, J., Arias, J. F., Bezgin, G., Matsudaira, T., Bunai, T., Obi, T., Tsukada, H., Ouchi, Y., & Rosa-Neto, P. (2022). Mitochondrial complex-I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer's disease. European journal of neurology, . https://doi.org/10.1111/ene.15246
Terada, Tatsuhiro, et al. "Mitochondrial complex-I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer's disease." European journal of neurology vol. (2022). doi: https://doi.org/10.1111/ene.15246
Terada T, Therriault J, Kang MS, Savard M, Pascoal TA, Lussier F, Tissot C, Wang YT, Benedet A, Poltronetti NM, Ottoy J, Arias JF, Bezgin G, Matsudaira T, Bunai T, Obi T, Tsukada H, Ouchi Y, Rosa-Neto P. Mitochondrial complex-I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer's disease. Eur J Neurol. 2022 Jan 10; doi: 10.1111/ene.15246. Epub 2022 Jan 10. PMID: 35007366.
Copy Download .nbib Format: NLM
High-frequency near-infrared diode laser irradiation suppresses IL-1β-induced inflammatory cytokine expression and NF-κB signaling pathways in human primary chondrocytes.

Lasers in medical science

Sakata S, Kunimatsu R, Tsuka Y, Nakatani A, Gunji H, Yanoshita M, Kado I, Ito S, Putranti NAR, Prasetya RC, Hirose N, Tanimoto K.
PMID: 34363129
Lasers Med Sci. 2021 Aug 07; doi: 10.1007/s10103-021-03371-5. Epub 2021 Aug 07.

Osteoarthritis (OA) and rheumatoid arthritis (RA) are common inflammation-associated cartilage degenerative diseases. Recent studies have shown that low-level diode laser treatment can reduce inflammatory cytokine expressions in cartilage. We recently reported that high-frequency low-level diode laser irradiation attenuates matrix...

Cite
Sakata S, Kunimatsu R, Tsuka Y, et al. High-frequency near-infrared diode laser irradiation suppresses IL-1β-induced inflammatory cytokine expression and NF-κB signaling pathways in human primary chondrocytes. Lasers Med Sci. 2021;doi: 10.1007/s10103-021-03371-5.
Sakata, S., Kunimatsu, R., Tsuka, Y., Nakatani, A., Gunji, H., Yanoshita, M., Kado, I., Ito, S., Putranti, N. A. R., Prasetya, R. C., Hirose, N., & Tanimoto, K. (2021). High-frequency near-infrared diode laser irradiation suppresses IL-1β-induced inflammatory cytokine expression and NF-κB signaling pathways in human primary chondrocytes. Lasers in medical science, . https://doi.org/10.1007/s10103-021-03371-5
Sakata, Shuzo, et al. "High-frequency near-infrared diode laser irradiation suppresses IL-1β-induced inflammatory cytokine expression and NF-κB signaling pathways in human primary chondrocytes." Lasers in medical science vol. (2021). doi: https://doi.org/10.1007/s10103-021-03371-5
Sakata S, Kunimatsu R, Tsuka Y, Nakatani A, Gunji H, Yanoshita M, Kado I, Ito S, Putranti NAR, Prasetya RC, Hirose N, Tanimoto K. High-frequency near-infrared diode laser irradiation suppresses IL-1β-induced inflammatory cytokine expression and NF-κB signaling pathways in human primary chondrocytes. Lasers Med Sci. 2021 Aug 07; doi: 10.1007/s10103-021-03371-5. Epub 2021 Aug 07. PMID: 34363129.
Copy Download .nbib Format: NLM
Huge carbuncle leading to necrotizing fasciitis in the COVID-19 pandemic era.

Clinical case reports

Gheisari M, Baghani M, Ganji R, Forouzanfar MM.
PMID: 33768893
Clin Case Rep. 2021 Jan 28;9(3):1583-1586. doi: 10.1002/ccr3.3839. eCollection 2021 Mar.

Although Necrotizing fasciitis can evolve from a trivial lesion, whenever it develops it requires a prompt surgical intervention and broad-spectrum antibiotic therapy.

Cite
Gheisari M, Baghani M, Ganji R, et al. Huge carbuncle leading to necrotizing fasciitis in the COVID-19 pandemic era. Clin Case Rep. 2021;9(3):1583-1586doi: 10.1002/ccr3.3839.
Gheisari, M., Baghani, M., Ganji, R., & Forouzanfar, M. M. (2021). Huge carbuncle leading to necrotizing fasciitis in the COVID-19 pandemic era. Clinical case reports, 9(3), 1583-1586. https://doi.org/10.1002/ccr3.3839
Gheisari, Mehdi, et al. "Huge carbuncle leading to necrotizing fasciitis in the COVID-19 pandemic era." Clinical case reports vol. 9,3 (2021): 1583-1586. doi: https://doi.org/10.1002/ccr3.3839
Gheisari M, Baghani M, Ganji R, Forouzanfar MM. Huge carbuncle leading to necrotizing fasciitis in the COVID-19 pandemic era. Clin Case Rep. 2021 Jan 28;9(3):1583-1586. doi: 10.1002/ccr3.3839. eCollection 2021 Mar. PMID: 33768893; PMCID: PMC7981722.
Copy Download .nbib Format: NLM
A Randomized Clinical Trial of Intratracheal Administration of Surfactant and Budesonide Combination in Comparison to Surfactant for Prevention of Bronchopulmonary Dysplasia.

Oman medical journal

Gharehbaghi MM, Ganji S, Mahallei M.
PMID: 34447583
Oman Med J. 2021 Jul 31;36(4):e289. doi: 10.5001/omj.2021.84. eCollection 2021 Jul.

OBJECTIVES: Bronchopulmonary dysplasia (BPD) remains a major problem in preterm infants occurring in up to 50% of infants born at < 28 weeks gestational age. Inflammation plays an important role in the pathogenesis of BPD. This study was conducted...

Cite
Gharehbaghi MM, Ganji S, Mahallei M. A Randomized Clinical Trial of Intratracheal Administration of Surfactant and Budesonide Combination in Comparison to Surfactant for Prevention of Bronchopulmonary Dysplasia. Oman Med J. 2021;36(4):e289doi: 10.5001/omj.2021.84.
Gharehbaghi, M. M., Ganji, S., & Mahallei, M. (2021). A Randomized Clinical Trial of Intratracheal Administration of Surfactant and Budesonide Combination in Comparison to Surfactant for Prevention of Bronchopulmonary Dysplasia. Oman medical journal, 36(4), e289. https://doi.org/10.5001/omj.2021.84
Gharehbaghi, Manizheh M, et al. "A Randomized Clinical Trial of Intratracheal Administration of Surfactant and Budesonide Combination in Comparison to Surfactant for Prevention of Bronchopulmonary Dysplasia." Oman medical journal vol. 36,4 (2021): e289. doi: https://doi.org/10.5001/omj.2021.84
Gharehbaghi MM, Ganji S, Mahallei M. A Randomized Clinical Trial of Intratracheal Administration of Surfactant and Budesonide Combination in Comparison to Surfactant for Prevention of Bronchopulmonary Dysplasia. Oman Med J. 2021 Jul 31;36(4):e289. doi: 10.5001/omj.2021.84. eCollection 2021 Jul. PMID: 34447583; PMCID: PMC8376750.
Copy Download .nbib Format: NLM
The Italian Deaf Community at the Time of Coronavirus.

Frontiers in sociology

Tomasuolo E, Gulli T, Volterra V, Fontana S.
PMID: 33869529
Front Sociol. 2021 Jan 14;5:612559. doi: 10.3389/fsoc.2020.612559. eCollection 2020.

The present paper will explore the impacts of the recent pandemic crisis on the Italian Deaf community, as a linguistic minority. Recent research has shown that minorities are suffering much more the effects of the pandemia because their lack...

Cite
Tomasuolo E, Gulli T, Volterra V, et al. The Italian Deaf Community at the Time of Coronavirus. Front Sociol. 2021;5:612559doi: 10.3389/fsoc.2020.612559.
Tomasuolo, E., Gulli, T., Volterra, V., & Fontana, S. (2020). The Italian Deaf Community at the Time of Coronavirus. Frontiers in sociology, 5612559. https://doi.org/10.3389/fsoc.2020.612559
Tomasuolo, Elena, et al. "The Italian Deaf Community at the Time of Coronavirus." Frontiers in sociology vol. 5 (2020): 612559. doi: https://doi.org/10.3389/fsoc.2020.612559
Tomasuolo E, Gulli T, Volterra V, Fontana S. The Italian Deaf Community at the Time of Coronavirus. Front Sociol. 2021 Jan 14;5:612559. doi: 10.3389/fsoc.2020.612559. eCollection 2020. PMID: 33869529; PMCID: PMC8022808.
Copy Download .nbib Format: NLM
The Relationship Between Selected Load-Velocity Profile Parameters and 50 m Front Crawl Swimming Performance.

Frontiers in physiology

Gonjo T, Njøs N, Eriksrud O, Olstad BH.
PMID: 33679439
Front Physiol. 2021 Feb 19;12:625411. doi: 10.3389/fphys.2021.625411. eCollection 2021.

The purpose of the present study was to establish relationships between sprint front crawl performance and a swimming load-velocity profile. Fourteen male national-level swimmers performed 50 m front crawl and semi-tethered swimming with three progressive loads. The 50 m...

Cite
Gonjo T, Njøs N, Eriksrud O, et al. The Relationship Between Selected Load-Velocity Profile Parameters and 50 m Front Crawl Swimming Performance. Front Physiol. 2021;12:625411doi: 10.3389/fphys.2021.625411.
Gonjo, T., Njøs, N., Eriksrud, O., & Olstad, B. H. (2021). The Relationship Between Selected Load-Velocity Profile Parameters and 50 m Front Crawl Swimming Performance. Frontiers in physiology, 12625411. https://doi.org/10.3389/fphys.2021.625411
Gonjo, Tomohiro, et al. "The Relationship Between Selected Load-Velocity Profile Parameters and 50 m Front Crawl Swimming Performance." Frontiers in physiology vol. 12 (2021): 625411. doi: https://doi.org/10.3389/fphys.2021.625411
Gonjo T, Njøs N, Eriksrud O, Olstad BH. The Relationship Between Selected Load-Velocity Profile Parameters and 50 m Front Crawl Swimming Performance. Front Physiol. 2021 Feb 19;12:625411. doi: 10.3389/fphys.2021.625411. eCollection 2021. PMID: 33679439; PMCID: PMC7933527.
Copy Download .nbib Format: NLM
Showing 457 to 465 of 465 entries